Trustee Report
Building Liverpool's fi'rst cancer hospital When Clatterbridge Cancer Centre Liverpool opened in June 2020, it did so with over £8 million of charitable funding to support the development of key areas, the purchase of specialised equipment and the best possible facilities. Building the safest, cleanest hospital suddenly taken ill and can be admitted for possible was particularly important when immediate care and assessment if needed. opening during the pandemic, with This will mean patients can be seen by a cancer patients being amongst the most cancer specialist rather than a lengthy wait vulnerable in the country. This made charity at an A&E and have direct admittance to an donations more important than ever. Some inpatient ward if necessary or more likely areas supported by donations included.. assessed, treated and can then return to the comfort of their own home. The Teenage and Young Adult Unit A therapeutic environment for young people with eight single en-suite beds in private rooms, a flexible social space, four chemotherapy treatment chairs and access to a rooftop garden terrace. Bone Marrow Transplant Units With a particular benefit to blood cancer patients, these 15 specialist isolation units, were built with bespoke HEPA-filtered air flow systems and have at least twelve air changes per hour, meaning that the air within the room will provide a protective environment in regards to filtration and pressurisation. They also feature an ante-room to ensure patients in isolation are protected during their treatment. Clinical Decision Unit This innovative department at the hospital provides a 2417 service for our patients who become unwell at home. Patients will be able to call the hotline from their home anytime during their treatment if they are ijirl.j
| Page | |||
|---|---|---|---|
| . | Repoit ofthe Trustees | 1to 2 | |
| Report ofthe Independent Auditors |
3to 4 | ||
| Statement ofFinancial | Activities | ||
| Balance Sheet | |||
| Cash Flow Statement | |||
| Notes to the Cash Flow Statement | |||
| Notes to the Financial | Statements | 9to 19 | |
| Detailed Statement of | Financial Activities | 20 |
| 31March 2021 31March 2020 | 31March 2021 31March 2020 | |||||||
|---|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total funds | Total funds | |||||
| fund | funds | |||||||
| Notes | f,'000 | K'000 | f,'000 | S'000 | ||||
| INCOMING RESOURCES | ||||||||
| Incoming resources from | generated | funds | ||||||
| Voluntary income |
1,207 | 148 | 1,355 | 1,481 | ||||
| Activities for generating funds |
860 | 860 | 1,599 | |||||
| Investment income |
29 | 29 | 70 | |||||
| Total incoming resources | 2,096 | 148 | 2,244 | 3,150 | ||||
| RESOURCES EXPENDED | ||||||||
| Costs ofgenerating funds |
||||||||
| Costs ofgenerating voluntary |
income | 714 | 714 | 883 | ||||
| Charitable activities |
||||||||
| Patients welfare | 2,120 | 959 | 3,079 | 7,074 | ||||
| Staffwelfare | 19 | 19 | 4 | |||||
| Research | 132 | 132 | 127 | |||||
| Other | 63 | 63 | 328 | |||||
| Governance costs |
19 | 19 | 15 | |||||
| Investment management |
charges | 9 | 9 | 9 | ||||
| Total resources expended | (3,076) | (959) | (4,035) | (8,440) | ||||
| NET INCOMING/(OUTGOING) | ||||||||
| RESOURCES | (980) | (811) | (1,791) | (5,290) | ||||
| Other recognised gains/losses |
||||||||
| Gains/losses on investment |
assets | 270 | 270 | ~129) | ||||
| Net movement in funds |
(710) | (811) | (1,521) | (5,419) | ||||
| RECONCILIATION OF |
FUNDS | |||||||
| Total funds brought forward | 1,922 | 955 | 2,877 | 8,296 | ||||
| TOTAL FUNDS CARRIED FORWARD | 1,212 | 144 | 1,356 | 2,877 |
| Balance Sheet At 31March 2021 |
|||||
|---|---|---|---|---|---|
| 31March 2021 | 31March 2020 | ||||
| Unrestricted | Restricted | Total funds | Total funds | ||
| fund | funds | ||||
| Notes | 6000 | f,'000 | 8000 | ||
| FIXEDASSETS | |||||
| Investments | 10 | 1,364 | 1,364 | I,lol | |
| CURRENT ASSETS | |||||
| Debtors | 12 | 12 | 12 | ||
| Cash at bank | 3,140 | 144 | 3,284 | 9,367 | |
| 3,152 | 144 | 3,296 | 9,379 | ||
| CREDITORS | |||||
| Amounts falling due within one year |
12 | (3,304) | (3,304) | (7,603) | |
| NET CURRENT ASSETS/(LIABILITIES) | ~152) | 144 | (8) | 1,776 | |
| TOTAL ASSETSLESSCURRENT | |||||
| LIABILITIES | 1,212 | 144 | 1,356 | 2,877 | |
| NET ASSETS | 1,212 | 144 | 1,356 | 2,877 | |
| FUNDS | 13 | ||||
| Unrestricted funds |
1,212 | 1,922 | |||
| Restricted funds | 144 | 955 | |||
| TOTAL FUNDS | 1,356 | 2,877 |
| 31March 2021 | 31 March 2020 | ||||||
|---|---|---|---|---|---|---|---|
| Notes | K'000 | f,'000 | |||||
| Net cash (outflow)/inflow | from operating | activities | 1 | (6,058) | 1,751 | ||
| Returns on investments | and servicing offinance | 2 | 42 | ||||
| Capital expenditure and |
financial investinent | 2 | (29) | ||||
| (Decrease)/increase in cash in the period |
~6,083) | 1,799 | |||||
| Reconciliation ofnet cash |
flow to movement | in net | |||||
| debt | |||||||
| (Decrease)/increase in cash |
in the period | ~6,083) | 1,799 | ||||
| Change in net debt resulting | fiom cash flows | (60S3) | 1,799 | ||||
| Movement in net debt in |
the period | (6,083) | 1,799 | ||||
| Net debt at 1April | 9,367 | 7,568 | |||||
| Net debt at31March | 3,284 | 9,367 |
| OPERATING AC | TIVI | TIES | |||
|---|---|---|---|---|---|
| 31March 2021 | 31March 2020 | ||||
| 1,9000 | f,'000 | ||||
| Net outgoing resources | (1,791) | (5,290) | |||
| Interest received | (5) | (36) | |||
| Online fees and bank charges | 16 | 19 | |||
| Investment fees |
9 | 9 | |||
| Dividends received |
(24) | (34) | |||
| Realised gains on sale of | investments | 36 | 1 | ||
| Decrease in debtors | 18 | ||||
| (Decrease)/increase | in creditors | ~4,299 | 7,064 | ||
| Net cash (outflow)/inflow | from operating | activities | ~6,058) | 1,751 |
| ANALYSIS OF CASH FLO | WS FOR HE | ADIN | GS NETTED IN THE CAS | H FLOW STATEM | ENT |
|---|---|---|---|---|---|
| 31March 2021 | 31March 2020 | ||||
| K'000 | X'000 | ||||
| Returns on investments and |
servicing offinance | ||||
| Interest received | 5 | 36 | |||
| Online fees and bank charges | (16) | (19) | |||
| Investment fees |
(9) | (9) | |||
| Dividends received |
24 | ||||
| Net cash inflow for returns | on investments | and | servicing offinance | 42 | |
| Capital expenditure and financial investment |
|||||
| Purchase offixed asset investments | (269) | (77) | |||
| Sale offixed asset investments | 240 | 83 | |||
| Net cash (outflow)/inflow for capital expenditure |
and financial investment | ~29) | |||
| ANALYSIS OF CHANGES | IN NET FUNDS |
| ANALYSIS OF CHANGES IN NET FU | NDS | ||
|---|---|---|---|
| At 1.4.20 | Cash flow | At 31March | |
| 2021 | |||
| f,'000 | f'000 | f'000 | |
| Net cash | |||
| Cash at bank | 9,367 | (6,0S3) | 3,284 |
| Total | 9,367 | L6,0S3) | 3,284 |
| VOLUNTARY INCOME | ||||||||
|---|---|---|---|---|---|---|---|---|
| 31 | March | 2021 | 31 | March | 2020 | |||
| Unrestricted | Restricted | Total | Total | |||||
| funds | funds | funds | funds | |||||
| F000 | 6000 | f,'000 | f.'000 | |||||
| Donations | 531 | 148 | 679 | 341 | ||||
| Legacies | 676 | 676 | 1,140 | |||||
| 1,207 | 148 | 1,355 | 1,481 |
| ACTIVITI | ES FOR GENERATI | NG FUNDS | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 31 | March | 2021 | 31 | March | 2020 | ||||
| Unrestricted | Restricted | Total | Total | ||||||
| funds | funds | funds | funds | ||||||
| f,'000 | f'000 | f'000 | f.'000 | ||||||
| Fundraising | events | 860 | 860 | 1,599 |
| 31March 2021 | 31 March 2020 | ||||
|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | ||
| funds | funds | funds | funds | ||
| K'000 | f,'000 | 8000 | 5'000 | ||
| Investments | . | 24 | 24 | 34 | |
| Other- bank | interest | 5 | 5 | 36 | |
| 29 | 29 | 70 |
| 31March 2021 | 31March 2020 | ||||
|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | ||
| funds | funds | funds | funds | ||
| K'000 | f'000 | R'000 | F000 | ||
| Fundraising | costs | 698 | 698 | 864 | |
| Online fees | and bank charges | 16 | 16 | 19 | |
| 714 | 714 | 883 |
| CHARITABLE ACTIVITIES | COSTS | |||
|---|---|---|---|---|
| Direct costs | 31March 2021 | 31March 2020 | ||
| Unrestricted | Restricted | Total | Total | |
| funds | funds | funds | funds | |
| f,'000 | f'000 | f'000 | 8000 | |
| Patients welfare | 2,120 | 959 | 3,079 | 7,074 |
| Staffwelfare | 19 | 19 | 4 | |
| Research | 132 | 132 | 127 | |
| Other | 63 | 63 | 328 | |
| 2,334 | 959 | 3,293 | 7,533 |
| 31 | March | 2021 | 31 | March | 2020 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | ||||||||
| funds | funds | funds | funds | ||||||||
| f.'000 | f.'000 | K'000 | f.'000 | ||||||||
| Auditors' | remuneration | 9 | 9 | 5 | |||||||
| Strategic | management | and | governance | 10 | 10 | 10 | |||||
| 19 | 19 | 15 |
| STAFF COSTS | ||
|---|---|---|
| 31March 2021 | 31March 2020 | |
| f'000 | K'000 | |
| Salaries and wages | 473 | 474 |
| Social security costs | 47 | 46 |
| Other pension costs | 66 | 62 |
| 586 | 582 |
| Listed | ||||
|---|---|---|---|---|
| investments | ||||
| F000 | ||||
| MARKET VALUE | ||||
| At 1 April 2020 | 1,101 | |||
| Additions | 269 | |||
| Disposals | (240) | |||
| Revaluations | 234 | |||
| At 31March 2021 | 1,364 | |||
| NKT BOOKVALUE | ||||
| At 31March 2021 | 1,364 | |||
| At 31March 2020 | 1,101 | |||
| 31March 2021 31March 2020 | ||||
| K'000 | 8000 | |||
| Historical cost at 31March | 890 | 871 | ||
| There were no investment | assets outside the UK. | |||
| The market value at 31 March: | ||||
| 31March 2021 31March 2020 | ||||
| f.'000 | .f.'000 | |||
| Investments listed on Stock Exchange |
1,313 | 1,080 | ||
| Cash held as part ofthe Investment | Portfolio | 51 | 21 | |
| 1,364 | 1,101 |
| DEBTORS: A.M | OUNTS FALLING DUE WIT | HIN ONE YEAR | |
|---|---|---|---|
| 31March 2021 | 31March 2020 | ||
| f'000 | K'000 | ||
| Estate income/gift | aid | 4 | |
| Dividends/interest | 4 | ||
| Other | 4 | ||
| Total | 12 | 12 |
| CREDITORS | : AMOUNTS FA | LLING DUE WITHIN ONE Y | EAR | ||
|---|---|---|---|---|---|
| 31March 2021 | 31 March 2020 | ||||
| f'000 | X'000 | ||||
| Other creditors | 3,304 | 7,603 | |||
| MOVEMENT | IN FUNDS | ||||
| Net | |||||
| At 1April | movement in |
At 31March | |||
| 2020 | funds | 2021 | |||
| f,'000 | F000 | F000 | |||
| Unrestricted funds |
|||||
| General fund | 1,922 | (710) | 1,212 | ||
| Restricted funds | |||||
| Restricted funds | 955 | (811) | 144 | ||
| TOTAL FUNDS | 2,877 | LI,521) | 1,356 | ||
| Net movement | in funds, included | in the above are as follows: | |||
| Incoming | Resources | Gains and | Movement in |
||
| resources | expended | losses | funds | ||
| K'000 | f'000 | f'000 | f'000 | ||
| Unrestricted funds |
|||||
| General fund |
2,096 | (3,076) | 270 | (710) | |
| Restricted funds | |||||
| Restricted funds |
148 | (959) | (811) | ||
| TOTAL FUNDS | 2,244 | (4,035) | 270 | (1,521) |
| Comparatives | for movement in funds |
|||
|---|---|---|---|---|
| Net | ||||
| At 1April | movement in |
At 31March | ||
| 2019 | funds | 2020 | ||
| f,'000 | f'000 | 6000 | ||
| Unrestricted | Funds | |||
| General fund | 7,472 | (5,550) | 1,922 | |
| Restricted Funds | ||||
| Restricted funds |
824 | 131 | 955 | |
| TOTAL FUNDS | 8,296 | (5,419) | 2,877 |
| Incoming | Resources | Gains and | Movement in |
|
|---|---|---|---|---|
| resources | expended | losses | funds | |
| f.'000 | f'000 | f.'000 | K'000 | |
| Unrestricted funds |
||||
| General fund | 3,01S | (8,439) | (129) | (5,550) |
| Restricted funds | ||||
| Restricted funds |
132 | 131 | ||
| TOTAL FUNDS | 3,150 | ~8,440) | (129) | (5,419) |
| Unrestricted | Restricted | Total | ||
|---|---|---|---|---|
| funds | funds | funds | ||
| 8000 | f,)000 | f'000 | ||
| Fixed assets | 1,101 | 1,101 | ||
| Current assets Creditors |
8,424 ~7,603) |
955 | 9,379 ~7,603) |
|
| Total | 1,922 | 955 | 2,877 | |
| Restricted funds | ||||
| 31March | 31 March | |||
| 2021 | 2020 | |||
| Macmillan Nurses |
based at CCC | 8,075 | 8,075 | |
| Gifts for Children | 1,351 | 1,351 | ||
| Thermoplastics | 6,250 | 6,250 | ||
| Wigs | 1,000 | 7,000 | ||
| Work in Southport | Area | 1,000 | 1,000 | |
| Pancreatic Cancer | Research | 75 | 75 | |
| TCC - Chemo at Home | 24,348 | |||
| Mattresses | 6,500 | 6,500 | ||
| TCC - Chemo Chair | 20,000 | |||
| TCC - Relatives Room | 277,000 | |||
| Bluebell Study | 6,000 | 6,000 | ||
| TCC - Therapy Room | 115,000 | |||
| TCC - Transplant | Suite | 150,000 | ||
| Inpatient Bedroom |
5,000 | |||
| Teenage Unit | 30,000 | |||
| Dementia Clocks | 460 | 460 | ||
| TYA Interactive TV | 5,000 | |||
| Sefton Residents Only |
359 | 359 | ||
| Fluroscopy Machine |
25,000 | |||
| TCC - Clinical Decisions Unit | 200,000 | |||
| Christmas Decorations |
742 | |||
| TCC Rooftop Tenace Level 6 | 40,000 | |||
| TCC Emma Rodgers Sculpture | 25,000 | |||
| Staff | 383 | 383 | ||
| COVID 19Staffand patients | 113,015 | |||
| 144,468 | 954,544 |
| 31March | 31March | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | |||||||||
| f.'000 | 8000 | |||||||||
| 705 | To support | the services | provided | by CCC | NHS FT | 181 | 625 | |||
| 701 | To support | the services | provided | by CCC | NHS FT | 35 | 292 | |||
| 702 | To provide | equipment | within the |
Diagnostic Imaging | Department | 10 | 10 | |||
| To support | in-patient services, particularly |
those provided | within Mersey | |||||||
| 709 | Ward | 8 | ||||||||
| 710 | To support | the services | provided | by CCC | NHS FT | 10 | ||||
| 712 | To support | the services | provided | by CCC | NHS FT | 6 | ||||
| 712 | To provide | equipment | within the | Diagnostic Imaging | Department | 8 | ||||
| To support | in-patient services, particularly |
those provided | within Mersey | |||||||
| 720 | Ward | |||||||||
| To support | in-patient services, particularly |
those provided | within Conway | |||||||
| 722 | Ward | |||||||||
| To support | Cancer Research, particularly | Breast Cancer, within CCC NHS | ||||||||
| 724 | FT | 40 | 41 | |||||||
| 725 | To support | Radiographers Training within |
CCC NHS | FT | 9 | 10 | ||||
| 739 | To support | Cancer Research within CCC | NHS FT | 44 | 46 | |||||
| 740 | To support | Cancer Research, particularly | Brain Cancer, within CCC NHS FT | 20 | 21 | |||||
| 743 | To support | Radiotherapy Services and Research within CCC |
NHS FT | 46 | 48 | |||||
| 747 | To support | the services | provided | by CCC | NHS FT | 31 | 32 | |||
| To support | Radiotherapy Services and Research, particularly |
Proton Therapy, | ||||||||
| 748 | within CCCNHS FT | 1 | 1 | |||||||
| 752 | To support | the services | provided | by CCC | NHS FT | 27 | 27 | |||
| 754 | To support | the services | provided | by CCC | NHS FT | 7 | 7 | |||
| 755 | To support | the services | provided | by CCC | NHS FT | 235 | ||||
| 756 | To support | the services | provided | by CCC | NHS FT | 12 | 13 | |||
| Unrealised | Gains/(loss) | on investments | 702 | 468 | ||||||
| 1,212 | 1,922 |
| 2020/21 | 2019/20 | |||
|---|---|---|---|---|
| f!000 | f.'000 | |||
| CCC Fundraising Costs (including |
salaries) | 745 | 899 | |
| Contribution | to Patients Welfare | 3,072 | 7,074 | |
| Contribution | to Staff Welfare | 2 | ||
| Contribution | to Research and Development | 131 | 120 | |
| Contribution | to Other Salaries | |||
| Contribution | to Capital | |||
| Governance | Costs | 10 | 10 | |
| Miscellaneous | 21 | 280 | ||
| Total | 3,979 | 8,385 |
| Detailed Statement ofFinancial | Detailed Statement ofFinancial | Detailed Statement ofFinancial | Activities | ||
|---|---|---|---|---|---|
| for the Year Ended 31March 2021 | |||||
| 31March 2021 | 31 March 2020 | ||||
| f.'000 | f'000 | ||||
| INCOMING RESOURCES | |||||
| Voluntary income |
|||||
| Donations | 679 | 341 | |||
| Legacies | 676 | 1,140 | |||
| 1,355 | 1,481 | ||||
| Activities for generating | funds | ||||
| Fundraising events |
860 | 1,599 | |||
| Investment income |
|||||
| Investments | 24 | 34 | |||
| Other- bank interest | 5 | 36 | |||
| 29 | 70 | ||||
| Total incoming resources | 2,244 | 3,150 | |||
| RESOURCES EXPENDED | |||||
| Costs ofgenerating | voluntary | income | |||
| Fundraising costs |
698 | 864 | |||
| Online fees and bank | charges | 16 | 19 | ||
| (714) | (883) | ||||
| Charitable activities |
|||||
| Patient welfare | 3,079 | 7,074 | |||
| Staffwelfare | 19 | .4 | |||
| Research | 132 | 127 | |||
| Other | 63 | 328 | |||
| (3,293) | (7,533) | ||||
| Governance costs |
|||||
| Auditors' remuneration |
9 | 5 | |||
| Strategic management | and | governance | 10 | 10 | |
| (19) | (15) | ||||
| Investment management |
charges | ||||
| Charges payable | (9) | ||||
| Total resources expended | (4,035) | (8,440) | |||
| Net expenditure | (1,791) | (5,290) |